Barely Significant

Excerpts

514,629 sentences

extremely significantP < 0.010.2× alphaqualified
Extremely significant differences ( P < 0.01) in plant height (PH), main stem node number (MSNN), pods per plant (PPP), seeds per plant (SPP), hundred seeds weight (HSW), yield per plant (YPP), root biomass (RB), stem biomass (STB), and pod biomass (PB) occurred between the tested varieties.
highly significantp < 0.010.2× alphaqualifiedgold
Figure 3 shows that correlations between the 90th percentile estimates of Stoffenmanager and calculated exposure scores using the new model are highly significant for all situations ( r = 0.93, p < 0.01), FRP lamination ( r = 0.67, p < 0.01), and inspection ( r = 0.85, p < 0.01).
highly significantP < 0.010.2× alphaqualifiedgold
At 4 weeks of intervention, compared with the Con group, the mRNA expression of AKT in the Mod group increased, with a highly significant difference ( P < 0.01); compared with the Mod group, the mRNA expression of AKT in the Acu + AMPK antagonist group and the Acu + ACC antagonist group decreased, with significant difference ( P < 0.05); compared with the Acu + AMPK antagonist group, the Acu + ACC antagonist group, the mRNA expression of AKT was increased with significant difference ( P < 0.05).
a significant trendP = 0.010.2× alphagold
The results demonstrate a significant trend in pain changes in the exercise group (F (2, 24) = 5.31, P = 0.01, η 2 = 0.31), while it is not significant in the control group (F (2, 30) = 0.57, P = 0.57, η 2 = 0.04).
a significant trendP < 0.010.2× alphagold
a nonsignificant trendP = 0.73514.7× alphagold
In the >4 weeks treatment duration subgroup, meta-analysis indicated a nonsignificant trend for reduction in SBP between experimental and control groups [WMD = 0.55, 95% CI (−2.63, 3.72), P = 0.735]; however, in the subgroup with treatment duration ≤ 4 weeks, there was a significant trend for reduction between the two groups [WMD = −4.42, 95% CI (−6.29, −2.20) P < 0.01] ( Figure 7 , Supplementary Figure 10 ) .
an increasing trendP = 0.010.2× alphagold
The overall mortality trend remained stable from 1999 to 2019 (AAPC: −0.09, 95% CI: −0.89 to 0.98), with an increasing trend in AAMRs from 1999 to 2006 (APC: 3.87, 95% CI: 1.15–9.68) ( P = 0.01), followed by a substantial decrease from 2006 to 2009 (APC: −18.95, 95% CI: −23.57 to −8.84) ( P = 0.0004), and a noticeable increase from 2009 to 2019 (APC: 3.52, 95% CI: 1.60–6.99) ( P = 0.001) (Graphical Abstract, Supplemental Digital Content 1, https://links.lww.com/CAEN/A70 ).
an overall trendP = 0.010.2× alphagold
Although plasma IL-6 levels did not significantly differ between pre-manifest and early HD patients ( g = −0.06, 95% CI = −0.42,0.31, P = 0.76), plasma IL-6 levels were significantly increased in moderate versus pre-manifest HD patients ( g = 0.48, 95% CI = 0.11,0.85, P = 0.01) and moderate versus early HD patients ( g = 0.52, 95% CI = 0.18,0.86, P = 0.003); demonstrating an overall trend of increasing plasma IL-6 levels with HD progression ( g = 0.32, 95% CI = 0.07,0.58, P = 0.01). 3.5.
moderately significantP < 0.010.2× alphaqualifiedgold
The recovery of GSH content in the treatment group with a dose of 800 mg/kg was highly significant ( P < 0.001), while the other treatment doses (100 and 300 mg/kg) showed moderately significant improvement ( P < 0.01), which was comparable to the replenishment of GSH level in the standard group ( P < 0.05). 3.4.4.